AKEBIA THERAPEUTICS INC (AKBA) Stock Institutional Trading Activity


AKEBIA THERAPEUTICS INC (AKBA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Baupost Group, and Abrams Capital Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2018Abrams Capital ManagementBuy1,119,2861,119,286$9,883
Q3 2018Renaissance Technologies LLCSell-742,1291,776,971$15,691
Q1 2018Renaissance Technologies LLCBuy697,9002,519,100$24,007
Q4 2017Renaissance Technologies LLCBuy400,3001,821,200$27,081
Q3 2017Renaissance Technologies LLCBuy395,6001,420,900$27,949
Q2 2017Renaissance Technologies LLCBuy639,0331,025,300$14,734
Q1 2017Renaissance Technologies LLCBuy177,667386,267$3,554
Q4 2016Renaissance Technologies LLCBuy56,800208,600$2,172
Q3 2016Renaissance Technologies LLCBuy127,500151,800$1,374
Q2 2016Renaissance Technologies LLCSell-4,20024,300$182
Q1 2016Renaissance Technologies LLCSell-80,70028,500$257
Q4 2015Renaissance Technologies LLCSell-1,500109,200$1,411
Q3 2015Renaissance Technologies LLCSell-270,539110,700$1,069
Q2 2015Renaissance Technologies LLCBuy381,239381,239$3,923

Frequently asked questions about AKBA activity

  • Which institutional owners are buying AKBA?

    Institutional owners buying AKBA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in AKBA activity?

    "Buy" means an investor increased their reported position in AKBA compared to the prior reporting period. This reflects growing exposure to AKEBIA THERAPEUTICS INC (AKBA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in AKBA increasing?

    Institutional interest in AKBA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.